- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06213064
A Direct-to-Consumer Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults
A Direct-to-Consumer, Randomized, Double-blind, Placebo-controlled, Double Cross-over Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults
Tetrahydrocannabivarin (THCV) is a rare cannabinoid and is a homologue of THC that differs only in the length of the alkyl side chain (3C vs 5C, respectively). Pre-clinical and clinical trials have shown that THCV has medical potential as a neuroprotectant, anti-inflammatory, anti-anxiety, and most notably as a therapeutic to improve glycemic control in type 2 diabetic patients.
Several THCV products are available in states with recreational cannabis. Anecdotal reports from adult cannabis users indicate that THCV provides an energizing, focusing and euphoric high-while still creating a lucid, uplifting experience. Additionally, unlike THC-dominant products, THCV was not reported to increase appetite. Other anecdotal comments referring to increased ability to focus for long periods of time and being more active were common.
Given anecdotal evidence, which shows that THCV is activating and improving focus, this provides rationale and justification to conduct a clinical research study to further test and understand whether THCV improves motivation, focus, level of energy, and does not stimulate appetite in healthy adults.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The rationale for this study is to determine the effect of a consumer-grade, state-legal formulation of cannabinoids including Tetrahydrocannabivarin (THCV) on motivation, energy level, focus, and appetite. A consumer-driven, decentralized observational clinical research study is therefore well suited to examine the effect of this formulation in healthy individuals.
The investigators will examine the outcomes in a broad age-range of adults who have chosen to try these products. The study will incorporate participant reported outcomes and surveys collected after each product use session to engage the participant in their typical day-to-day activities. There is no "physician-patient" relationship as part of this research since the participant as a consumer is making the informed choice to take the products and take part in the observational process with self-reported measures. Findings from this study will contribute knowledge toward the design of future cannabis research studies and the improvement of the product formulation.
A new study questionnaire was developed as no existing questionnaire would be able to capture all interest areas of this study in a holistic manner. Other questionnaires related to focus, attention, concentration, fatigue, work, and motivation were assessed and used to support the study questionnaire development.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Amy Kazaryan, MPhil
- Phone Number: 8184528996
- Email: amy@peoplescience.health
Study Contact Backup
- Name: Crisel Erfe, MD
- Phone Number: 310-922-0609
- Email: crisel@peoplescience.health
Study Locations
-
-
California
-
Los Angeles, California, United States, 90034
- Recruiting
- People Science, Inc.
-
Contact:
- Crisel Erfe, MD
- Phone Number: 310-922-0609
- Email: crisel@peoplescience.health
-
Contact:
- Amy Kazaryan, MPhil
- Phone Number: 818-452-8996
- Email: amy@peoplescience.health
-
Principal Investigator:
- Noah Craft, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy adults age > 21 years old
- Work / study / play in an environment that requires focus
- Able to read and understand English
- Able to read, understand, and provide informed consent
- Able to use a personal smartphone device and download Chloe by People Science
- Able to complete study assessments over the course of up to 14 days
- Familiar with the use of cannabis and its effects
- Able to tolerate at least 5mg THC
- Willingness to abstain from use of any THC containing products during study product use days
- Willingness to abstain from use of alcohol during study product use days
- Greater Los Angeles area residents only
Exclusion Criteria:
- Participants who do not have a smartphone and/or internet access
- Any known adverse effects from taking cannabis
- Concomitant Therapies: Currently taking medication for ADHD or psychotropic medications
Other Illnesses or Conditions: Participants who have the following co-morbidities are excluded:
- History or currently undergoing product use for substance abuse disorders
- Currently pregnant, planning to become pregnant within the next month, or breastfeeding
- Allergies to formulation ingredients
- Current or prior psychotic disorder
- Immunosuppressive product uses, including organ transplant participants, active immunotherapy for cancer product use
- Any condition that is considered by investigator to be a contraindication to cannabis (e.g. specific drug-use interaction, unstable cardiac arrhythmia)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study Product, THC Only Product, Placebo
All study participants will receive and cross-over into each group: study product, thc-only product, and placebo groups. Study Product Ingredient List: Active Ingredients: 10mg THCV, 5mg THC Tapioca syrup, sugar, water, pectin, citric acid, natural flavors*, coconut oil, sodium citrate, cannabis extract, soy lecithin, Infused THC Gummy Ingredient List: Active Ingredients: 5mg THC Tapioca syrup, sugar, water, pectin, citric acid, natural flavors*, coconut oil, sodium citrate, cannabis extract, soy lecithin, THC. Non-infused Placebo Gummy Ingredient List: Tapioca syrup, sugar, water, pectin, citric acid, natural flavors*, coconut oil, sodium citrate, soy lecithin. |
Participants will complete up to a seven week study consisting of screening period, baseline period, up to a 21-day product use period with a total of 9 product use sessions.
Screening assessments, baseline questions, product use period questionnaires, adverse event reporting, and end of study experience survey data will be collected.
This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study.
Participants will receive the study product during the baseline period.
Demographic and medical history data will be collected for the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To observe the effect of various cannabinoid-containing products on motivation.
Time Frame: 3 weeks
|
Change in average motivation score by 1 point as measured by a 10-point visual analogue rating scale (VAS) collected between cannabinoid and placebo use sessions.
The scale is between 1-10, where 1 denotes 'Strongly Disagree' and 10 denotes 'Strongly Agree.'
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To observe the effect of cannabinoid products on motivation, energy level, focus, and appetite (MEFA).
Time Frame: 3 weeks
|
Change in average score by 1 point as measured by a 10-point visual analogue rating scale (VAS) between the cannabinoid and placebo use sessions.
The scale is between 1-10, where 1 denotes 'Strongly Disagree' and 10 denotes 'Strongly Agree.'
|
3 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To observe changes in overall symptoms and quality of life.
Time Frame: 3 weeks
|
Changes in overall symptoms and quality of life to be assessed based on a qualitative evaluation of study participant experiences.
|
3 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Noah Craft, MD, People Science, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PS04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Motivation
-
ThinkWellUniversity of Oxford; Queen's University, Belfast; The BMJCompleted
-
Centre Hospitalier Universitaire de NiceLaboratoire Motricité Humaine, Expertise, Sport, Santé (LAMHESS); Côte d'Azur...Not yet recruiting
-
Nourhan M.AlyAlexandria UniversityCompleted
-
University of Southern DenmarkUnknown
-
University Hospital, CaenCompleted
-
Kahramanmaras Sutcu Imam UniversityRecruiting
-
Northeastern UniversityMassachusetts General Hospital; National Institute on Aging (NIA)Unknown
Clinical Trials on Study Product, THC Product, Placebo
-
Radicle ScienceActive, not recruitingSleep Disorder | Sleep | Sleep DisturbanceUnited States
-
Radicle ScienceActive, not recruitingCognitive FunctionUnited States
-
Radicle ScienceActive, not recruitingRadicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health OutcomesFatigue | EnergyUnited States
-
Radicle ScienceRecruitingPain | Neuropathic Pain | Nociceptive PainUnited States
-
Radicle ScienceActive, not recruitingStress | AnxietyUnited States
-
Radicle ScienceCompletedStress | AnxietyUnited States
-
Radicle ScienceActive, not recruitingFatigue | EnergyUnited States
-
Radicle ScienceCompletedDepression | Pain | Sleep | AnxietyUnited States
-
Shenzhen Precision Health Food Technology Co. Ltd...CompletedOverweight and ObesityChina
-
Shenzhen Precision Health Food Technology Co. Ltd...Active, not recruiting